Life Sciences. KIST has been strengthening international relationships by promoting joint research through the exchange of human resources and information and currently has cooperative agreements with 51 research institutes in 24 countries. KIST also has interest in transferring its technology and experience with developing countries.
The Symposium began with opening remarks from distinguished peoples: Dr Dong Hwa Kum, KIST president; Dr Sang Mok Lee, Korea Ministry of Science and Technology; Dr Young Seek Lee, Korea Biotech R&D Group; and Dr Sung Wan Kim, Utah University. After a keynote lecture by Dr. Allan Hoffman, University of Washington, 9 renowned scientists invited from the USA, China, Japan, and Germany and 9 Korean speakers gave presentations covering topics in polymeric materials in macro-and nano-scales, general drug delivery and targeting, and protein and gene delivery systems. The discussions were focused mainly on the future of drug delivery system development. The speakers and their topics follow:
History of the evolution of "Controlled" drug delivery systems from macroscopic to microscopic to nano-scale. This lecture reviewed the historical evolution of "controlled" drug delivery devices, implants and formulations during the past 50 years. & Thomas Kissel, Philipps-Universität, Germany
Biodegradable nano-carriers based on branched polyesters: A platform for nanoscale drug delivery? Poly(2-sulfobutyl vinyl alcohol)-g-poly(lactide-co-glycolide), SB-PVAL-g-PLGA were investigated for the preparation of nanospheres and self-aggregating colloidal systems with defined surface properties. Polymeric nanoparticles for protein delivery. To achieve an optimum therapeutic effect by sustained release of the protein drugs, core/shell nanoparticles were designed and evaluated. & Hirofumi Takeuchi, Gifu University, Japan
Novel particle design for drug delivery. The basic concept of polymer-coating liposome particles was reviewed as one of the typical colloidal drug carriers and the drug-delivery performance of these carriers with mucoadhesive was studied for oral administration of peptide drugs. & Kang Choon Lee, Sungkyunkwan University, South Korea PEGylated insulinotropic peptides for type 2 diabetic therapy. The Symposium was a huge success,, attended by 400 scientists, many of whom were students and early-career scientists. For additional information about the Symposium and KIST, please contact the chair of the symposium, Dr. SooChang Song (scsong@kist.re.kr).
